A case study of spironolactone induced gynecomastia in one male patient with cir-rhosis
10.3969/j.issn.1006-0111.2017.02.017
- VernacularTitle:1例螺内酯致男性肝硬化患者乳房发育的不良反应分析
- Author:
Zhonghui SUN
1
;
You WANG
;
Haijie DUAN
;
Yuegui TAN
;
Le LIANG
;
Hongping YAO
Author Information
1. 西安交通大学第一附属医院药学部
- Keywords:
spironolactone;
cirrhosis;
gynecomastia;
adverse drug reactions
- From:
Journal of Pharmaceutical Practice
2017;35(2):165-166,170
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study one male patient with cirrhosis for spironolactone induced gynecomastia and promote clinical pharmacists providing better pharmaceutical cares .Methods Based on the patient′s diseases and medication history , clinical pharmacists searched related literature and analyzed the cause of gynecomastia for the patient .Results The patient′s breast pain was relieved and finally disappeared after termination of spironolactone .Therefore ,spironolactone was suspected to be the drug to cause gynecomastia .Conclusion Clinical pharmacists can improve pharmaceutical cares by carefully monitoring the adverse reactions and selecting appropriate medications .
